XtalPi Holdings (HKG:2228) is looking to raise HK$2.08 billion by placing about 342.9 million shares at HK$6.10 apiece.
The new shares represent 8.52% of the company's enlarged issued share capital, according to a Wednesday filing with the Hong Kong bourse.
The drug discovery and automation solutions firm plans to use the deal proceeds for product upgrades, R&D and technology enhancements, product commercialization, business development, investments, and acquisitions.
XtalPi said it may increase the size of its investment and commitment to projects related to AI models linked to chemistry and antibodies, laboratory intelligence, traditional Chinese medicine, new materials, and new energy.
Shares of the company were up by about 8% in recent trading.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。